MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

24 Jan 2019 Evaluate

Glenmark Pharmaceuticals has informed about submission of a media release titled ‘Glenmark Pharmaceuticals receives tentative ANDA approval for Topiramate Extended? Release Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg’,  which is self explanatory. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..